Anish Patel, CHIEF OPERATING OFFICER at Enliven Therapeutics, Inc. (ELVN), sold 13,334 shares at $21.93 ($292K) on 2025-02-07, disclosed to the SEC on 2025-02-10.
Open-market sale of $292k ELVN by CHIEF OPERATING OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.93 | 6,667 | $146K | 50.0% |
| 2 | $21.93 | 6,667 | $146K | 50.0% |
| Total | $21.93 avg | 13,334 | $292K | 100% |
| Filing → |
| ELVN | SELL | 2025-11-12 | $221K | — | Filing → |
| ELVN | SELL | 2025-10-09 | $268K | — | Filing → |
| ELVN | SELL | 2025-09-10 | $270K | — | Filing → |